Literature DB >> 2571039

OKT3-induced cytokine release attenuation by high-dose methylprednisolone.

M Goldman, D Abramowicz, L De Pauw, M L Alegre, I Widera, P Vereerstraeten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2571039     DOI： 10.1016/s0140-6736(89)90864-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatment.

Authors:  G J Zlabinger; K M Stuhlmeier; R Eher; S Schmaldienst; R Klauser; A Vychytil; B Watschinger; O Traindl; J Kovarik; E Pohanka
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

Review 2.  Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.

Authors:  A J Olyaei; A M de Mattos; W M Bennett
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

3.  In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants.

Authors:  K J Parlevliet; I J ten Berge; S L Yong; J Surachno; J M Wilmink; P T Schellekens
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

4.  Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.

Authors:  L Schandené; P Vandenbussche; A Crusiaux; M L Alègre; D Abramowicz; E Dupont; J Content; M Goldman
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

5.  The effect of methylprednisolone on monocyte eicosanoid production in patients with multiple sclerosis.

Authors:  P F Kirk; J D Williams; M M Petersen; D A Compston
Journal:  J Neurol       Date:  1994-06       Impact factor: 4.849

Review 6.  Immunomodulation of transplant rejection using monoclonal antibodies and soluble receptors.

Authors:  M L Alegre; D J Lenschow; J A Bluestone
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

7.  Characterization of a new mouse model for peripheral T cell lymphoma in humans.

Authors:  Niklas Beyersdorf; Sandra Werner; Nelli Wolf; Thomas Herrmann; Thomas Kerkau
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.